Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

42
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
42
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

700
Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
700
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

1.4K
Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
1.4K
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

45
Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
45
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

26
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
26
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

301
Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
301

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Association of Thyroid Hormone Levels and Thyroid Hormone Sensitivity with Adverse Clinical Outcomes in Euthyroid Patients with Ischemic Stroke.

Current neurovascular research·2026
Same author

Plasma choline and betaine and neurological function trajectory after acute ischemic stroke.

BMC neurology·2026
Same author

Mismatch-time ratio combined with ASPECTS: a novel indicator of favorable prognosis in multimodal ct prediction of anterior circulation large vessel occlusion.

BMC neurology·2026
Same author

Impacts of Remnant Cholesterol and Residual Inflammation on Clinical Outcomes After Ischemic Stroke.

JACC. Advances·2026
Same author

Multiple Cardiac Biomarkers and Long-Term Neurological Deficits Trajectory After Ischemic Stroke.

Journal of the American Heart Association·2026
Same author

Renal function and effect of early antihypertensive therapy in acute ischaemic stroke: a subgroup analysis of the CATIS-2 trial.

Stroke and vascular neurology·2026

相关实验视频

Updated: Sep 19, 2025

Dual-Task Stroop Paradigm for Detecting Cognitive Deficits in High-Functioning Stroke Patients
07:42

Dual-Task Stroop Paradigm for Detecting Cognitive Deficits in High-Functioning Stroke Patients

Published on: December 16, 2022

3.1K

残留胆固醇和中风后的认知功能:一个多中心前性研究.

Hong Li1, Zhengbao Zhu2, Mengyao Shi2

  • 1Department of Epidemiology, School of Public Health, Chongqing Medical University, Chongqing, China.

Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia
|June 9, 2025
PubMed
概括
此摘要是机器生成的。

升高的残留胆固醇 (RC) 水平与三个月后脑卒中后认知障碍 (PSCI) 的风险较低有关. 这种保护作用在没有超重症的个体中更为明显.

关键词:
认知障碍 认知障碍是一种认知障碍.缺血性中风是因为缺血性中风.剩余的胆固醇是剩余的

更多相关视频

Evaluation of the Cognitive Performance of Hypertensive Patients with Silent Cerebrovascular Lesions
07:30

Evaluation of the Cognitive Performance of Hypertensive Patients with Silent Cerebrovascular Lesions

Published on: April 23, 2021

3.1K
Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

14.8K

相关实验视频

Last Updated: Sep 19, 2025

Dual-Task Stroop Paradigm for Detecting Cognitive Deficits in High-Functioning Stroke Patients
07:42

Dual-Task Stroop Paradigm for Detecting Cognitive Deficits in High-Functioning Stroke Patients

Published on: December 16, 2022

3.1K
Evaluation of the Cognitive Performance of Hypertensive Patients with Silent Cerebrovascular Lesions
07:30

Evaluation of the Cognitive Performance of Hypertensive Patients with Silent Cerebrovascular Lesions

Published on: April 23, 2021

3.1K
Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

14.8K

科学领域:

  • 神经学 神经学
  • 心血管医学 心血管医学
  • 代谢障碍 代谢障碍 代谢障碍

背景情况:

  • 脑卒中后认知障碍 (PSCI) 是继缺血性脑卒中后的一个常见并发症.
  • 剩余胆固醇 (RC),计算为总胆固醇减去LDL-C和HDL-C,是一个新兴的心血管风险因素.
  • 基线RC水平和PSCI之间的关联仍然不完全理解.

研究的目的:

  • 为了研究基线残留胆固醇 (RC) 水平和中风后三个月的脑功能障碍 (PSCI) 发生率之间的关系.
  • 确定RC水平是否预测了经历过急性缺血性中风的患者的认知结果.

主要方法:

  • 利用了来自中国抗高血压试验在急性缺血性中风 (CATIS) 的数据.
  • 使用公式计算基线残留胆固醇 (RC) 水平:RC = TC - LDL-C - HDL-C.
  • 在三个月后使用迷你心理状态检查 (MMSE) 和蒙特利尔认知评估 (MoCA) 评估认知功能.
  • 采用二进制物流回归来分析RC tertiles和PSCI之间的关联,并对相关的共变量进行调整.

主要成果:

  • 这项前性研究包括523名参与者.
  • 基线RC的最高三位数与最低三位数 (OR:0.38;95%CI:0.23-0.63) 相比,显著与PSCI风险降低有关.
  • 在多变量调整 (OR:0.40,95% CI:0.21-0.75) 后,这种关联仍然存在.
  • 在BMI ≤24.9 kg/m2的患者中,较高的RC三位数显示PSCI风险降低 (OR:0.32和0.16),BMI>24.9 kg/m2的患者没有看到这种效果 (相互作用P=0.036).

结论:

  • 升高的基线残留胆固醇水平与三个月后发展中风后认知障碍的风险降低有关.
  • 这种保护性关联在不超重的缺血性中风患者中尤其明显.
  • 剩余的胆固醇可以作为潜在的生物标志物,用于脑中风后的认知结果.